The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Interactions Between the Intestinal Microbiome and Liver Diseases
Open accessAbstract
The human intestine harbors a diverse community of microbes that promote metabolism and digestion in their symbiotic relationship with the host. Disturbance of its homeostasis can result in disease. We review factors that disrupt intestinal homeostasis and contribute to nonalcoholic fatty liver disease, steatohepatitis, alcoholic liver disease, and cirrhosis. Liver disease has long been associated with qualitative and quantitative (overgrowth) dysbiotic changes in the intestinal microbiota. Extrinsic factors, such as the Western diet and alcohol, contribute to these changes. Dysbiosis results in intestinal inflammation, a breakdown of the intestinal barrier, and translocation of microbial products in animal models. However, the contribution of the intestinal microbiome to liver disease goes beyond simple translocation of bacterial products that promote hepatic injury and inflammation. Microbial metabolites produced in a dysbiotic intestinal environment and host factors are equally important in the pathogenesis of liver disease. We review how the combination of liver insult and disruptions in intestinal homeostasis contribute to liver disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the impact of changes to the composition and function of the microbiome in NASH include altered bile acid metabolism and loss of integrity of the gut-vascular barrier, precipitating leakage of LPS and bacteria into the liver via the portal circulation (14–16).”
From Hepatic Stellate Cell-Immune Interactions in NASH (2022) · cites this paper as [14]
In the citing paper
“Changes in gut microbiota (dysbiosis) may play a key role in the pathogenesis of NAFLD/NASH and cholestasis52–54 and may also impact on BA composition and signalling.51 55”
From Novel therapeutic targets for cholestatic and fatty liver disease (2022) · cites this paper as [54]
In the citing paper
“However, a failing gut barrier and alterations of the gut microbiota in chronic liver disease (CLD) contribute to chronic inflammation and the progression of liver diseases12, and thereby increase risk for the development of hepatocellular carcinoma (HCC) as the final stage of the disease process 13–15.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [12]
In the citing paper
“Metagenomic studies have revealed substantial alterations in the composition of the gut microbiota in a range of CLD as well as in patients with cirrhosis12,32.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [12]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
A core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823
Linking long-term dietary patterns with gut microbial enterotypes
Wu, G. D., Chen, J., Hoffmann, C., Bittinger, K., Chen, Y.-Y., Keilbaugh, S. A., Bewtra, M., Knights, D., Walters, W. A., Knight, R., et al. (2011) · Science · doi:10.1126/science.1208344 · Cited by 6,513
The gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245
Obesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597
Intestinal mucosal barrier function in health and disease
Turner, J. R. (2009) · Nature reviews. Immunology · doi:10.1038/nri2653 · Cited by 3,952
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk
Tang, W. H. W., Wang, Z., Levison, B. S., Koeth, R. A., Britt, E. B., Fu, X., Wu, Y., & Hazen, S. L. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1109400 · Cited by 3,400
Mechanisms underlying the resistance to diet-induced obesity in germ-free mice
Bäckhed, F., Manchester, J. K., Semenkovich, C. F., & Gordon, J. I. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605374104 · Cited by 2,615
Flagged first, then by citations
Cited by
Sorted by citations
Items 801–900 of 974
Experimental Workflow for Preclinical Studies of Human Antifibrotic Therapies
Reolizo, L., Matsuda, M., & Seki, E. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3207-9_18 · Cited by 2
Leoni, F. P., Puccinelli, C., Pelligra, T., Gori, E., Marchetti, V., Diana, A., Linta, N., & Citi, S. (2023) · Open Veterinary Journal · doi:10.5455/ovj.2023.v13.i5.6 · Cited by 2
A Summary of the Second Annual HIV Microbiome Workshop
Williams, B., Ghosh, M., Boucher, C. A., Bushman, F. D., Carrington‐Lawrence, S., Collman, R. G., Dandekar, S., Dang, Q., Malaspina, A., Paredes, R., et al. (2017) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2017.0137 · Cited by 2
Microbial Therapeutics in Liver Disease
Bajaj, J. S., & Khoruts, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00193-6 · Cited by 2
Mei, W., Feng, Y., Yao, Z., Luo, H., Ni, Y., & Zhao, R. (2020) · doi:10.21203/rs.3.rs-35344/v1 · Cited by 2
Liu, Q., Nie, Y., Zhang, W., Wan, Y., Huang, C., & Zhu, X. (2021) · Research Square · doi:10.21203/rs.3.rs-516318/v1 · Cited by 2
Skladaný, Ľ., Kubánek, N., Selčanová, S. A., Žilinčanová, D., Šoltýs, K., Messingerová, L., Lichvár, M., Lafférs, L., Havaj, D. J., Sulejova, K. K., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-3918795/v1 · Cited by 2
Symbiotic association of gut microbiome in health and diseases at ageing
Mane, S. S., Patel, D. A., & Patil, P. C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99334-0.00049-9 · Cited by 1
Microbial Diversity and Their Role in Human Health and Diseases
Bhat, M. H., Hajam, Y. A., Neelam, N., Kumar, R., & Diksha, D. (2023) · Springer eBooks · doi:10.1007/978-981-99-3126-2_1 · Cited by 2
Impact of High-Temperature Feeds on Gut Microbiota and MAFLD
Xue, L., Li, K., Jia, Y., Yao, D., Guo, X., & Zhang, S. (2024) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2405.05023 · Cited by 1
Xiong, L., Zou, J., Lin, K., Zhang, X., Yan, C., He, Y., & Zhang, J. (2025) · Toxicology Letters · doi:10.1016/j.toxlet.2025.04.006 · Cited by 1
Mo, J., Su, W., Qin, J., Feng, J., Yu, R., Li, S., Lv, J., Dong, R., Cheng, Y., & Han, B. (2025) · Microorganisms · doi:10.3390/microorganisms13071696 · Cited by 2
Pacheco-Barcía, V., Méndez, A. M., Hernández-Jiménez, E., Jiménez‐Fonseca, P., Martín, A. J. M., Custodio‐Cabello, S., Palka-Kotlowska, M., Gonzalez-Diaz, I., & Cabezón‐Gutiérrez, L. (2025) · World Journal of Clinical Oncology · doi:10.5306/wjco.v16.i10.107877 · Cited by 1
Wang, N., Jia, D., & Ge, X. (2025) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.25-122 · Cited by 1
Hao, Z., Li, X., Li, Z., Ma, M., Xi, Y., Yu, L., Wang, Y., Zhang, B., Xu, Y., & Zhang, L. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1705483 · Cited by 1
Shi, F., Yang, Z., Zhang, L., Zou, D., Yu, J., Guo, N., Ren, S., Tang, X., Gu, C. J., Xu, R., et al. (2025) · Microbiome · doi:10.1186/s40168-025-02233-4 · Cited by 1
Intestinal decontamination with rifaximin attenuates LSEC dysfunction and liver fibrosis in mice
Su, T., Lai, S., & Chen, H. (2026) · PLoS ONE · doi:10.1371/journal.pone.0340664 · Cited by 1
León, F. J. F., & Pujol, F. H. (2026) · Livers · doi:10.3390/livers6010011 · Cited by 1
Zahra, M., Ouf, A. A., Azzazy, H. M. E., & Moustafa, A. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1758563 · Cited by 1
Gu, Z., Meng, S., Yao, B., Gao, B., Chen, S., Ren, F., Li, P., Shao, T., & Shang, N. (2026) · Nature Communications · doi:10.1038/s41467-026-72211-3 · Cited by 2
Solis, M. N., Šefcová, M. A., Larrea-Álvarez, C. M., Szabóová, R., Herich, R., & Larrea-Álvarez, M. (2026) · Healthcare · doi:10.3390/healthcare14111551 · Cited by 1
Zhou, N., Tan, B., Jiang, Y., Wang, H., Peng, W., Yin, M., Fu, L. Y., & Peng, S. (2026) · Journal of Inflammation Research · doi:10.2147/jir.s598139 · Cited by 1
Faisal, S., Ullah, I., Kambey, P. A., Malik, A., Ejaz, M. R., Shah, S. A., & Li, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1861669 · Cited by 1
Abe, K., Takahashi, A., & Ohira, H. (2016) · Springer eBooks · doi:10.1007/978-4-431-55790-6_2 · Cited by 1
The Microbiome and Human Disease: A New Organ of Interest in Biliary Disease
Hov, J. R. (2017) · Springer eBooks · doi:10.1007/978-3-319-50168-0_5 · Cited by 1
Hepatitis B Virus, Hepatitis C Virus, the Microbiome, and Hepatocellular Carcinoma
Chen, F., Freyer, C., Gong, L., & Zekry, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-54843-4.00004-0 · Cited by 1
Healthy gut microbiome in the prevention of colorectal cancer
Rumman, M., Nagasaka, M., Al-Share, B. A., Azmi, A. S., & Uddin, M. H. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822238-6.00005-4 · Cited by 1
Arabinogalactan Prevented APAP-Induced Acute Liver Injury by Regulating the Intestinal Flora in Mice
Jiang, D., Zhang, D., Zhou, S., & Wang, X. (2023) · Lecture notes in computer science · doi:10.1007/978-3-031-25191-7_5 · Cited by 1
Review: Microbial Therapeutics for Liver Disease
Philips, C. A., & Augustine, P. (2023) · JOURNAL OF GASTROINTESTINAL INFECTIONS · doi:10.1055/s-0043-1768145 · Cited by 1
Gut microbiota and acute kidney injury: immunological crosstalk link
Ali, A. M. M., Wu, L., & Ali, S. S. (2023) · International Urology and Nephrology · doi:10.1007/s11255-023-03760-5 · Cited by 1
Narad, P., Gupta, R., Kulshrestha, S., & Sengupta, A. (2024) · Springer eBooks · doi:10.1007/978-981-99-9462-5_17 · Cited by 1
Wunderlich, M., Miller, M., Ritter, B., Gleut, R. L., Marchi, H., Majzoub‐Altweck, M., Knerr, P. J., Douros, J. D., Müller, T. D., & Brielmeier, M. (2024) · Molecular Metabolism · doi:10.1016/j.molmet.2024.101992 · Cited by 1
Jiménez-González, C., Vallejo, I. G., Sordo, D., Medina, J. M., Alonso‐Peña, M., & Crespo, J. (2024) · Current Hepatology Reports · doi:10.1007/s11901-024-00670-7 · Cited by 1
Ohshima, K., Torii, S., & Shimizu, S. (2024) · Genes to Cells · doi:10.1111/gtc.13183 · Cited by 1
The Gut Microbiome and Cirrhosis: Basic Aspects
Wiest, R. (2015) · Springer eBooks · doi:10.1007/978-3-319-23018-4_18 · Cited by 2
Intestinal gas and liver steatosis: a casual association? A prospective multicentre assessment
Maconi, G., Furfaro, F., Fries, W., Dell’Era, A., Bezzio, C., Costantino, G., Giuliano, V., Alibrandi, A., Guzowski, T., & Bassotti, G. (2016) · Liver International · doi:10.1111/liv.13198 · Cited by 1
The Role of the Bacterial Microbiota in Alcoholic and Non-alcoholic Fatty Liver Disease
Madsen, A. L., Brach, T., Kern, T., Bak, E. G., Nielsen, T., & Arumugam, M. (2018) · Springer eBooks · doi:10.1007/978-3-319-98890-0_6 · Cited by 1
Microbial Profiles of Cirrhosis in the Human Small Intestine
Dong, T. S., Jacobs, J. P., & Hussain, S. K. (2019) · Current Gastroenterology Reports · doi:10.1007/s11894-019-0717-2 · Cited by 1
Small Intestinal Bacterial Overgrowth
Sorathia, S. J., & Rivas, J. M. (2019) · StatPearls · Cited by 1
Хроническая алкогольная интоксикация и коморбидные расстройства кишечника (обзор литературы)
Никифоров, И. А., Бурыгина, Л. А., Белова, М. Ю., & Kostyuk, G. P. (2021) · Естественные и Технические Науки · doi:10.37882/2223-2966.2021.05-2.19 · Cited by 1
Yang, H., Jin, X., Cheng, T., Shan, G., Lu, C., Gu, J., Zhan, C., Xu, F., & Ge, D. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.859352 · Cited by 2
Protein Diet and Management of Hepatic Encephalopathy: An Overview of the Last Decade Controversy
Aimrane, A., Ait-Laaradia, M., Fdil, N., Warda, K., Chatoui, H., Draoui, A., Baz, S. E., El‐Mansoury, B., Zouhairi, N., Sabir, E., et al. (2022) · Springer eBooks · doi:10.1007/978-3-030-93971-7_15 · Cited by 1
Gridnyev, O., Fadieienko, G. D., Kushnir, I. Е., & Gridnieva, S. V. (2023) · Modern Gastroenterology · doi:10.30978/mg-2023-1-55
Fitzpatrick, E. (2015) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000000809 · Cited by 1
Novel insights into toxic and chronic liver disease
Zoubek, M. E. (2021) · Research Publications (Maastricht University) · doi:10.26481/dis.20210929mz · Cited by 1
Teeman, C. S. (2021) · FIU - Digital Commons (Florida International University) · doi:10.25148/etd.fidc010264 · Cited by 1
Winkler, S. (2014) · Qucosa (Saxon State and University Library Dresden)
Review article: NONALCOHOLIC FATTY LIVER DISEASE, DIET AND GUT MICROBIOTA
Finelli, C., Tarantino, G., & Lucia, S. M. (2014)
Nonalcoholic Fatty Liver Disease (NAFLD) after Liver Transplantation: A Mini-Review
de Oliveira, C. P. M. S., & Álvares‐da‐Silva, M. R. (2015) · Journal of Liver Disease & Transplantation · doi:10.4172/2325-9612.1000127
Tomita, K., & Hokari, R. (2015) · Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine · doi:10.2169/naika.104.48
Alcoholic Beverage and Insulin Resistance–Mediated Degenerative Diseases of Liver and Brain
de la Monte, S. M., Huse, S. M., & Kim, M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801585-8.00019-1
Brandl, K., & Schnabl, B. (2016) · Wiley eBooks · doi:10.1002/9781118982907.ch22
Self-citationDelarue, J., & Lallès, J. P. (2016) · Cahiers de Nutrition et de Diététique · doi:10.1016/j.cnd.2016.09.002
Bukong, T. N., Saha, B., & Szabó, G. (2016) · Springer eBooks · doi:10.1007/978-4-431-56101-9_5
Gut Microbiome and their metabolic impact: New frontier
Pandeya, D. R. (2017) · Annals of Clinical Chemistry and Laboratory Medicine · doi:10.3126/acclm.v2i2.17068
ER Stress in Drug-Induced Liver Injury
Hinton, M. R., Li, Y., Kwong, E. K., & Zhou, H. (2017) · Springer eBooks · doi:10.1007/978-3-319-53774-0_2
Gut Microbiota: The Missing Link in Obesity Induced Nonalcoholic Liver Disease
Rattan, R., Panda, P., & Mahapatra, S. (2017) · IOSR Journal of Pharmacy and Biological Sciences · doi:10.9790/3008-1201010811
Fatty liver diseases: Recent advances and challenges
Wang, H., & Gao, B. (2018) · Liver Research · doi:10.1016/j.livres.2018.03.002
Cutting-edge topics in the pathophysiology of alcoholic liver disease
Ikejima, K. (2018) · Kanzo · doi:10.2957/kanzo.59.342
The Role of microRNAs in the Gut-Liver Axis
Georgiou, S., Pantazopoulou, V. I., & Anastasiadou, E. (2018) · Springer eBooks · doi:10.1007/978-3-319-98890-0_13
Effect of Intestinal Flora Clearance on Liver Proteomics in Mice
Jia, Z., Liu, H., Song, M. L., Yang, C., Zhao, Y., Wu, X., Wu, Z., & Zhao, L. (2018) · Current Proteomics · doi:10.2174/1570164616666181115102046
Novel insights into the role of bacterial gut microbiota in hepatocellular carcinoma
Chang, R., Zhang, L., Qiu, G., Xu, X., & Zhou, Y. (2018) · Cancer translational medicine · doi:10.4103/ctm.ctm_8_18
Microbiota in Non-alcoholic Liver Disease
Ogawa, Y., Honda, Y., Kessoku, T., Tomeno, W., Imajo, K., Yoneda, M., Saito, S., & Nakajima, A. (2019) · Springer eBooks · doi:10.1007/978-981-13-1465-0_9
Le microbiote et les stéatopathies métaboliques
Buffet, C. (2014) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)31172-0
Budd–Chiari Syndrome and Paroxysmal Nocturnal Hemoglobinuria
Brodsky, A., & Cordini, G. (2019) · Springer eBooks · doi:10.1007/978-981-32-9232-1_7
Bruns, T., & Stallmach, A. (2020) · Die Gastroenterologie · doi:10.1007/s11377-020-00436-9
Intestinal Microbiome and the Liver
Gillevet, P. M., & Puri, P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-37591-7.00003-3
Chen, Z., Han, S., Zheng, P., Zhang, J., Zhou, S., & Jia, G. (2020) · Research Square · doi:10.21203/rs.3.rs-84918/v1
Ghadimi, M. (2021) · Annals of Gastroenterology · doi:10.20524/aog.2021.0601 · Cited by 2
Gut Microbiome and Liver Cancer
McVey, J. C., Zhang, Q., Greten, T. F., & Ma, C. (2021) · Physiology in health and disease · doi:10.1007/978-3-030-67951-4_7
Cartilage-hair Hypoplasia Complicated with Liver Cirrhosis Due to Chronic Intrahepatic Cholestasis
Kogami, T., Uojima, H., Ebato, T., Bando, Y., Hoshino, A., Saegusa, M., Ohbu, M., Iwasaki, S., Wada, N., Kubota, K., et al. (2021) · Internal Medicine · doi:10.2169/internalmedicine.7483-21
Gut Microbiota Characterization in Patients with HCC Post Chronic HCV InfectionPreprint
Montasser, K. A., Osman, H. A., Abozaid, H. S. M., & sabry, A. M. M. (2020) · doi:10.21203/rs.3.rs-29305/v1
Minimal hepatic encephalopathy – underestimated complication of chronic liver disease
Bogdanowska-Charkiewicz, D., Rogalski, P., Dâbrowski, A., & Daniluk, J. (2021) · Neuropsychiatria i Neuropsychologia · doi:10.5114/nan.2021.108031
The Art of Mesenchymal Stem Cells in Liver Fibrosis Management
Amansyah, F., & Anurogo, D. (2021) · Bioinformatics and Biomedical Research Journal · doi:10.11594/bbrj.03.02.03
Impact of age at appendectomy on development of HCC: A population-based cohort study
Lee, Y.-M., & Kor, C. (2021) · SCIREA Journal of Clinical Medicine · doi:10.54647/cm32404
Rashid, H., Ishtiaq, S. M., Hussain, Z., Faisal, M. N., Anwar, H., Qureshi, A. S., Rasheed, M. U., Rasheed, M., Riaz, A., & Khan, J. A. (2021) · The Journal of Animal and Plant Sciences · doi:10.36899/japs.2022.1.0403
Immune dysregulation in nonalcoholic steatohepatitis
Chatterjee, A., & Basu, P. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821232-5.00023-9
Mann, A., Czaja, M. J., & Schattenberg, J. M. (2015) · Wiley eBooks · doi:10.1002/9781118663387.ch14
Arabinogalactan prevented APAP-induced acute liver injury by regulating the intestinal flora in micePreprint
Wang, D., Zhou, S., & Wang, X. (2022) · Research Square · doi:10.21203/rs.3.rs-1380093/v1
Liver Dysfunction and Failure: Clinical Presentation, Pathophysiology, and Management
Yoshino, O. (2022) · Hot topics in acute care surgery and trauma · doi:10.1007/978-3-030-92241-2_13
Arabinogalactan prevented APAP-induced acute liver injury by regulating the intestinal flora in micePreprint
Wang, D., Zhou, S., & Wang, X. (2022) · Research Square · doi:10.21203/rs.3.rs-1380093/v2
The Microbiome and Cancer: A Dangerous Liaison
Meisel, A. (2021) · healthbook TIMES Oncology Hematology · doi:10.36000/hbt.oh.2021.08.035
Impact of the gut microbiome on human health and diseases
Banik, S. P., Sehgal, S., Ghosh, R. B., & Das, A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822238-6.00026-1 · Cited by 1
Helicobacter Pylori Infection and its Associated Genes in Egyptian Patients with Liver Cirrhosis
MEDHAT, M. D. H. F. E., MAKHZANGY, M. D. A. K. H. E., & MOHAMED Z. HAIDER, M. D. ;. Z. Z. (2022) · The Medical Journal of Cairo University/The Medical Journal of Cairo University · doi:10.21608/mjcu.2022.253196
Liver Cancer: Interdisciplinary Approach
Zhang, H., Zhao, J., Yang, W., Li, Z., Gong, L., & Li, Y. (2022) · Interdisciplinary cancer research · doi:10.1007/16833_2022_96
Abshire, K. M., & Leggio, L. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-823453-2.00013-8
Jin, X., Wu, J., Wang, C., Tang, B., Yang, H., & Liu, Y. (2023) · doi:10.22541/au.167587024.47659435/v1
Associations between Probiotic Exposure and Hepatic Steatosis: A nationwide cross-sectional studyPreprint
Song, Y., Guo, W., Wang, J., Liu, S., Li, Z., Zhao, L., Guo, D. L., & Li, Y. (2023) · Research Square · doi:10.21203/rs.3.rs-2633651/v1
EFFECT OF BACTERIAL INFECTION ON THE PROTOSCOLECES DEGENERATION OF HYDATID CYSTS IN SHEEP
Al-Sabawi, B. H., Al-Sultan, S. A. H., & Abudlhameed, I. A. (2023) · Military Medical Science Letters · doi:10.31482/mmsl.2022.058
Song, Y., Guo, W., Wang, J., Liu, S., Li, Z., Zhao, L., Guo, D. L., & Li, Y. (2023) · Research Square · doi:10.21203/rs.3.rs-2870959/v1
Probiotic-based Anticancer Immunity In Hepato-cellular Carcinoma (liver Cancer)
Shah, F., & Dwivedi, M. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815124781123030011
Las alteraciones de la microbiota intestinal en la patogenia del hígado graso no alcohólico
Guiñez, D. V., Jaime Poniachik, T., Gotteland, M., Magne, F., Urzua, A. M., Alexis Iracheta, M., de Arce, E. P., Ana María Madrid, S., Luis Araya, C., Daniela Vera, P., et al. (2018) · Revista Hospital Clínico Universidad de Chile · doi:10.5354/2735-7996.2018.70322
Probiotics Role in Liver Diseases A Magic Bullet
Kedarisetty, C. K., Vangara, S., & Prabhakar, V. (2023) · Acta Scientific Gastrointestinal Disorders · doi:10.31080/asgis.2023.06.0545
Menżyk, T., Skladaný, Ľ., Selčanová, S. A., Vnenčáková, J., Žilinčanová, D., Bystrianska, N., Hudy, D., Skonieczna, M., Marlicz, W. M., & Kukla, M. (2023) · Clinical and Experimental Hepatology · doi:10.5114/ceh.2023.132255
Dong, Y., Zhang, Y.-P., Jiang, X., Xie, Z., Li, B., Jiang, N.-H., Chen, S., & Lv, G. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4664335
Wang, S., Fu, W., Zhao, X., Chang, X., Liu, H., Zhou, L., Li, J., Cheng, R., Wu, X., Li, X., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22604585
Metadata
- Authors
- Schnabl, B., & Brenner, D. A.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Schnabl, Bernd
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2014-05
- Volume
- 146
- Issue
- 6
- Pages
- 1513-1524
- ISSN
- 0016-5085 (ISSN-L)
- PMC
- PMC3996054
- OpenAlex
- W1975691929
- Cited by
- 971
- References
- 86
- Citations by year
- 2026: 37 · 2025: 56 · 2024: 88 · 2023: 101 · 2022: 88 · 2021: 92 · 2020: 102 · 2019: 88 · 2018: 89 · 2017: 58 · 2016: 64 · 2015: 77 · 2014: 31
- FWCI
- 7.23
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institutes of Health (U01 AA021856, R01 AA020703, 2 P42 ES010337, K08 DK081830)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Keywords
- gut microbiota, gut-liver axis, non-alcoholic fatty liver disease, steatohepatitis, alcoholic liver disease, liver cirrhosis, dysbiosis, intestinal homeostasis, intestinal barrier dysfunction, intestinal inflammation, microbial translocation, microbial metabolites, Western diet, alcohol
- MeSH terms
- Animals, Bacteria, Bile Acids and Salts, Fatty Liver, Humans, Intestines, Liver Cirrhosis, Liver Diseases, Liver Diseases, Alcoholic, Risk Factors, Host-Pathogen Interactions, Microbiota, Dysbiosis, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
